No Data
Realcan Pharmaceutical Group (002589.SZ): Share repurchase has not yet been implemented.
Gelonghui January 9丨 Realcan Pharmaceutical Group (002589.SZ) announced that as of December 31, 2024, the company has not yet implemented a share buyback.
Realcan Pharmaceutical Group (SZSE:002589) Stock Falls 10% in Past Week as Five-year Earnings and Shareholder Returns Continue Downward Trend
Realcan Pharmaceutical Group (002589.SZ) will distribute 0.07 yuan for every 10 shares in the first three quarters, with the equity registration date on November 28.
realcan pharmaceutical group (002589.SZ) has announced that the company will implement equity distribution for the first three quarters of 2024, to all...
Realcan Pharmaceutical Group (002589.SZ): plans to invest 0.1 to -0.2 billion yuan in repurchasing shares.
GeLongHui, November 10th | Realcan Pharmaceutical Group (002589.SZ) announced that the company plans to use its own funds and special loan funds for share buyback to repurchase some of the company's issued Renminbi ordinary shares (A shares) through centralized bidding trading to be used for employee shareholding plans or stock-based incentives in the future at an appropriate time after the implementation of the share buyback results and share changes announcement, and to be transferred within three years; the repurchase amount shall not be less than RMB 100 million (inclusive) and not more than RMB 200 million (inclusive); the repurchase price shall not exceed RMB 4.5 per share. The company has obtained approval from China's securities regulatory authority.
Ruikang Pharmaceutical: Report for the third quarter of 2024
Realcan Pharmaceutical Group (SZSE:002589) Earnings and Shareholder Returns Have Been Trending Downwards for the Last Five Years, but the Stock Soars 12% This Past Week
Benign Growth For Realcan Pharmaceutical Group Co., Ltd. (SZSE:002589) Underpins Stock's 30% Plummet
